SOO-lin-dak 
Contraindicated in:
Use Cautiously in:
CNS: dizziness, headache, drowsiness.
EENT: blurred vision, tinnitus.
CV: HF, MYOCARDIAL INFARCTION, STROKE, edema, hypertension.
GI: GI BLEEDING, DRUG-INDUCED HEPATITIS, constipation, diarrhea, discomfort, dyspepsia, nausea, vomiting, anorexia, flatulence, pancreatitis.
GU: renal failure.
Derm: EXFOLIATIVE DERMATITIS, STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, rash, photosensitivity.
Hemat: blood dyscrasias, prolonged bleeding time.
Misc: ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS AND HYPERSENSITIVITY SYNDROME.
Drug-Drug:
Absorption: Well absorbed from the GI tract after oral administration.
Distribution: Unknown. Enters breast milk in small amounts.
Metabolism/Excretion: Converted by the liver to active drug. Minimal amounts excreted unchanged by the kidneys.
Half-life: 7.8 hr (16.4 hr for active metabolite).
| ROUTE | ONSET | PEAK | DURATION |
|---|---|---|---|
| PO (analgesic) | 1–2 days | unknown | 12 hr |
| PO (anti-inflammatory) | few days–1 wk | 2 wk or more | unknown |
NDC Code*